CorVent Medical's Respond Ventilator Receives FDA Clearance
核心洞察
CorVent Medical (搜索) secured FDA 510(k) clearance for its Respond critical care ventilator, designed for simple, safe, and cost-effective ventilation.
The Respond ventilator combines traditional mechanical ventilation with durable components, eliminating service contracts and using non-proprietary accessories.
Engineered for pediatric to adult patients, Respond features standard breathing modes, invasive/non-invasive ventilation, and a patient-prioritized alarm system.
CorVent Medical (搜索) has announced that its Respond critical care ventilator system has received FDA 510(k) clearance. The Respond ventilator is designed to provide a cost-effective and reliable option for delivering ventilation in various healthcare settings. The clearance marks a significant step for U.S. manufacturing in the medical device sector, being the first ventilator manufactured in the U.S. to receive FDA clearance in over two decades.
The Respond ventilator combines traditional mechanical ventilation elements with durable, long-lasting components. This design aims to reduce the total cost of ownership by eliminating the need for service and maintenance contracts and utilizing non-proprietary circuits and accessories. The ventilator operates with low-pressure oxygen, further contributing to its long-term affordability.
Key Features and Benefits
According to CorVent, the Respond ventilator is engineered to meet the needs of a broad range of patients, from pediatric to adult. It includes all standard breathing modes and offers both invasive and non-invasive ventilation capabilities. Additional features include a patient-prioritized alarm system, hot-swappable batteries, and communication capabilities for EMR integration.
Dr. Patrick Troy, chief medical officer at CorVent Medical (搜索), emphasized the ventilator's value proposition: “Simple and highly reliable, the Respond ventilator is a front-line ventilator in a value-focused and resource-constrained world. Its robust design maximizes total cost of ownership, delivering significant savings for hospital systems, emergency stockpiles, long-term acute care hospitals (LTACHs) and skilled nursing facilities (SNFs).”
Company Statement
Richard S. Walsh, President and CEO, stated, “Achieving FDA 510(k) clearance for the RESPOND ventilator is a testament to our commitment to advancing medical technology and addressing the critical needs of patients and healthcare professionals. This accomplishment not only reinforces our dedication to innovation but also marks a significant step in revitalizing U.S. manufacturing in the medical device sector.” The company plans to expand its product line with additional value-based solutions for its customers.